Word

BIOWATECH

Status

Dead

Status Code

606

Status Date

Thursday, October 20, 2005

Serial Number

78214735

Mark Type

1000

Filing Date

Thursday, February 13, 2003

Published for Opposition

Tuesday, July 27, 2004

Abandoned Date

Thursday, October 20, 2005

Trademark Owner History

Kyowa Hakko Kogyo Co., Ltd. - Owner At Publication

Classifications

1 Biochemicals, namely, monoclonal antibodies, fragments of such antibodies and derivatives of such antibodies for in vitro scientific or research use; cells for scientific, laboratory or medical research cells that manufacture antibody, fragment of antibody or derivatives of antibody; cells for scientific, laboratory or medical research, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; host cells for scientific, laboratory or medical research

5 Cells for medical or clinical use that manufacture antibodies, fragments of antibodies or derivatives of antibodies; cells for medical or clinical use, namely, transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; host cells for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopitnitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs far treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in viva use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, antiparkinsonism drugs, minor tranquilizers, and antianxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, vitamins, anti-bacterial preparations, mucolytic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro exiracorporeal diagnostic reagents for medical use, in vitro X-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases

40 Custom manufacturing of antibodies, fragments of such antibodies and derivatives of such antibodies; custom manufacturing of cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; custom manufacturing of transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; custom manufacturing of host cells

42 Contract development of antibodies, fragments of such antibodies and derivatives of such antibodies; contract development of cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; contract development of transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies; contract development of host cells

Trademark Events

Dec 22, 2005

Abandonment Notice Mailed - No Use Statement Filed

Dec 22, 2005

Abandonment - No Use Statement Filed

Apr 15, 2005

Extension 1 Granted

Apr 15, 2005

Extension 1 Filed

Apr 15, 2005

Teas Extension Received

Oct 19, 2004

Noa Mailed - Sou Required From Applicant

Jul 27, 2004

Published For Opposition

Jul 7, 2004

Notice Of Publication

May 21, 2004

Approved For Pub - Principal Register

Apr 22, 2004

Correspondence Received In Law Office

Mar 24, 2004

Final Refusal Mailed

Mar 3, 2004

Assigned To Examiner

Feb 9, 2004

Correspondence Received In Law Office

Feb 9, 2004

Teas Response To Office Action Received

Aug 12, 2003

Non-Final Action Mailed

Aug 8, 2003

Assigned To Examiner